Michelle Lofwall, MD

University of Kentucky

Disclosure(s): Braeburn Pharmaceuticals: Advisor/Consultant; Camurus: Honoraria

Poster(s):

• (P-1863) Integrated outpatient treatment of Serious Injection-Related Infections and Opioid Use Disorder: the Buprenorphine plus Outpatient Parenteral Antibiotic Therapy (BOPAT) Clinical Trial
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET